GHRP-6
Animal / preclinicalWADA prohibitedAlso known as: Growth Hormone Releasing Peptide-6
Community-reported ranges are anecdotal and not clinically validated. Evidence grade shown reflects the strength of available human data. Not a prescription. Legal status varies by country and changes over time; verify locally.
Overview
One of the original growth-hormone-releasing peptides, distinctive for the strong hunger response that makes it popular in appetite- and mass-focused phases. GH release is its established effect; formal physique outcome trials haven't been run.
Mechanism
Ghrelin-receptor agonist stimulating GH release, with a pronounced ghrelin-like appetite effect.
Evidence
GH release and the appetite effect are well described mechanistically; physique outcomes rest on that plus community experience.
Community-reported information
Community reports vary. Anecdotal and unvalidated; general information only.
General information only, not tailored to you and not a recommendation. Some regions withhold this entirely.
Half-life
Short (under an hour).
Storage
Refrigerate lyophilised and reconstituted.
Commonly reported side effects
- Intense hunger
- Water retention
- Raised cortisol/prolactin
Legal status by region
- USNot FDA-approved for human use.
Legal status changes over time; verify locally before relying on this.
Citations
- GHRP-6 researchPubMed
- WADA Prohibited ListWADA